Table 2 Characteristics of pediatric cases with native liver who underwent percutaneous liver biopsy stratified by major complications during hospitalization
Characteristics | Category | Cases without major complication (Nā=ā1297) | Cases with major complication (Nā=ā13) | Total (Nā=ā1310) | p-value |
|---|---|---|---|---|---|
Sex | Male | 728 (56.1) | 6 (46.2) | 734 (56.0) | 0.58 |
Age (years) | 10 (5ā15) | 3 (0ā10) | 10 (5ā15) | 0.006 | |
Age (years) | ā<ā1 | 44 (3.4) | 4 (30.8) | 48 (3.7) | <ā0.001 |
1ā5 | 316 (24.4) | 4 (30.8) | 320 (24.4) | ||
6ā11 | 357 (27.5) | 3 (23.1) | 360 (27.5) | ||
12ā17 | 580 (44.7) | 2 (15.4) | 582 (44.4) | ||
BMI or BMI-SDS | Underweight | 137 (10.6) | 3 (23.1) | 140 (10.7) | 0.24 |
Normal | 920 (70.9) | 9 (69.2) | 929 (70.9) | ||
Overweight or obesity | 240 (18.5) | 1 (7.7) | 241 (18.4) | ||
CCC score | āā¤ā1 | 1075 (82.9) | 11 (84.6) | 1086 (82.9) | ā„ā0.99 |
āā„ā2 | 222 (17.1) | 2 (15.4) | 224 (17.1) | ||
Comorbidities on admission | Anemia or coagulation diseases | 61 (4.7) | 4 (30.8) | 65 (5.0) | 0.003 |
Cancers other than liver cancer | 12 (0.9) | 0 (0.0) | 12 (0.9) | ā„ā0.99 | |
Liver cancer | 11 (0.8) | 6 (46.2) | 17 (1.3) | <ā0.001 | |
Acute liver failure | 52 (4.0) | 1 (7.7) | 53 (4.0) | 0.42 | |
Liver cirrhosis | 154 (11.9) | 1 (7.7) | 155 (11.8) | ā„ā0.99 | |
Biliary atresia | 239 (18.4) | 0 (0.0) | 239 (18.2) | 0.14 | |
Inborn errors of metabolism | 151 (11.6) | 3 (23.1) | 154 (11.8) | 0.19 | |
Autoimmune hepatitis | 86 (6.6) | 1 (7.7) | 87 (6.6) | 0.59 | |
Unscheduled admission | 82 (6.3) | 3 (23.1) | 85 (6.5) | 0.047 | |
Corticosteroid use | 42 (3.2) | 0 (0.0) | 42 (3.2) | ā„ā0.99 | |
Immunosuppressant use | 56 (4.3) | 0 (0.0) | 56 (4.3) | ā„ā0.99 | |
Previous liver biopsies history | 308 (23.7) | 1 (7.7) | 309 (23.6) | 0.32 | |
Hospital volume per year (cases) | 1ā17 | 823 (63.5) | 7 (53.8) | 830 (63.4) | 0.33 |
18ā54 | 336 (25.9) | 3 (23.1) | 339 (25.9) | ||
āā„ā55 | 138 (10.6) | 3 (23.1) | 141 (10.8) | ||